30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Kim Kelderman

Insider profile

Currently holds a position at Bio-Techne Corp

Performance

Overall performance
3.7

Performance over holding periods
3.7
30 days 90 days 120 days
Average return 14% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
President - Diagnostics and Genomics Bio-Techne Corp April 30, 2018 -

Kim Kelderman's trades of Bio-Techne Corp's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-29 2025-01-27 S Sale
53,190 -44.1%
118.12
US$1,984,795
53,190 -44.1% 118.12 US$1,984,795
2025-01-29 2025-01-27 S Sale
56,153 -47.7%
336.86
US$2,342,535
56,153 -47.7% 336.86 US$2,342,535
2025-01-27 2025-01-27 PrS Proposed sale
27,875
169.89
US$2,043,312
27,875 169.89 US$2,043,312
2021-11-23 2021-11-19 S Sale
400 -100.0%
505.78
US$202,313
400 -100.0% 505.78 US$202,313
2021-11-23 2021-11-19 S Sale
100 -20.0%
503.76
US$50,376
100 -20.0% 503.76 US$50,376
2021-02-09 2021-02-05 S Sale
823 -49.3%
388.45
US$319,694
823 -49.3% 388.45 US$319,694